Inhibition of lymphocyte blastogenic response in healthy donors treated with recombinant human granulocyte colony-stimulating factor (rhG-CSF): Possible role of lactoferrin and interleukin-1 receptor antagonist

Bone Marrow Transplantation

Volumn 20, Issue 5, 1997, Pages 355-364

  Rutella, S ^a,d   Rumi, C ^a   Testa, U ^b   Sica, S ^a   Teofili, L ^a   Martucci, R ^b   Peschle, C ^b,c   Leone, G ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^d CATHOLIC UNIVERSITY   (Italy)

Author keywords

Flow cytometry; G CSF; Lymphocyte blastogenesis

Indexed keywords

CD19 ANTIGEN; CD23 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; CONCANAVALIN A; DNA; HLA DR ANTIGEN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 2 RECEPTOR; LACTOFERRIN; PHYTOHEMAGGLUTININ; POKEWEED MITOGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BACKACHE; BLOOD LEVEL; CLINICAL TRIAL; DNA SYNTHESIS; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LEUKOCYTE COUNT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE TRANSFORMATION; MALE; MONOCYTE; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030822084     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700899     Document Type: Article

References (42)

1. Bensinger WI, Price TH, Dale DC et al. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993; 81: 1883-1888.
2. Bensinger WI, Weaver CH, Appelbaum FR et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995; 85: 1655-1658.
3. Bensinger WI, Clift R, Anasetti C et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Stem Cells 1996; 14: 90-105.
4. Russell JA, Brown C, Bowen T et al. Allogeneic blood cell transplants for haematological malignancy: preliminary comparison of outcomes with bone marrow transplantation. Bone Marrow Transplant 1996; 17: 703-708.
5. Rosenfeld C, Collins R, Pineiro L et al. Allogeneic blood cell transplantation without post-transplant colony-stimulating factors in patients with hematopoietic neoplasm: a phase II study. J Clin Oncol 1996; 14: 1314-1319.
6. Urbano-Ispizua A, Solano C, Brunei S et al. Allogeneic peripheral blood progenitor cell transplantation: analysis of short-term engraftment and acute GVHD incidence in 33 cases. Exp Hematol 1996; 18: 35-40.
7. Schmitz N, Dreger P, Suttorp M et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 1995; 85: 1666-1672.
8. Hirokawa M, Kitabayashi A, Niitsu H et al. Modulation of allogeneic immune responses by filgrastim (recombinant human granulocyte colony-stimulating factor) in bone marrow transplantation, Int J Hematol 1995; 62: 235-241.
9. Kitabayashi A, Hirokawa M, Hatano Y et al. Granulocyte colony-stimulating factor down-regulates allogeneic immune responses by post-transcriptional inhibition of tumor necrosis factor-α production. Blood 1995; 86: 2220-2227.
10. Ohsaka A, Saionji K, Kuwaki T et al. Granulocyte colony-stimulating factor administration modulates the surface expression of effector molecules on human monocytes. Br J Haematol 1995; 89: 465-472.
11. Matsunaga T, Sakamaki S, Kohgo Y et al. Recombinant human granulocyte colony-stimulating factor can mobilize sufficient amounts of peripheral blood stem cells in healthy volunteers for allogeneic transplantation. Bone Marrow Transplant 1993; 11: 103-108.
12. Rumi C, Rutella S, Sica S et al. Impairment of lymphocyte blastogenic response in healthy donors treated with rhG-CSF. Exp Hematol 1996; 24: 1147 (Abstr. 675).
13. Sica S, Rutella S, Di Mario A et al. RhG-CSF in healthy donors: mobilization of peripheral hemopoietic progenitors and effect on peripheral blood leukocytes. J Hematother 1996; 5: 391-397.
14. Talmadge JE, Reed EC, Kessinger A et al. Immunologie attributes of cytokine mobilized peripheral blood stem cells and recovery following transplantation. Bone Marrow Transplant 1996; 17: 101-109.
15. Mills KC, Gross TG, Varney ML et al. Immunologie phenotype and function in human bone marrow, blood stem cells and umbilical cord blood. Bone Marrow Transplant 1996; 18: 53-61.
16. Bussa S, Rumi C, Leone G, Bizzi B. Evaluation of a new whole blood cytometric lymphocyte transformation test for immunological screening. J Clin Lab Immunol 1993; 40: 39-46.
17. Van Pelt LJ, Huisman MV, Weening RS et al. A single dose of granulocyte-macrophage colony-stimulating factor induces systemic interleukin-8 release and neutrophil activation in healthy volunteers. Blood 1996; 87: 5305-5313.
18. Grigg AP, Roberts AW, Raunow H et al. Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers. Blood 1995; 86: 4437-4445.
19. Romagnani S, Del Prete G, Maggi E et al. CD30 and type 2 T helper (Th2) responses. J Leuk Biol 1995; 57: 726-730.
20. Nash PV, Mastro AM. Activation of primary lymphocytes requires prolonged lectin stimulation. J Leuk Biol 1993; 53: 73-78.
21. Schmid I, Uittenbogaart CH, Giorgi JV. A gentle fixation and permeabilization method for combined cell surface and intra-cellular staining with improved precision in DNA quantification. Cytometry 1991; 11: 279-285.
22. Shankey TV, Rabinovitch PS, Bagwell B et al. Guidelines for implementation of clinical DNA cytometry. Cytometry 1993; 14: 472-477.
23. Testa U, Martucci R, Rutella S et al. Autologous stem cell transplantation: release of early-and late-acting growth factors relates with hematopoietic ablation and recovery. Blood 1994; 84: 3532-3539.
24. Strauss RG. Therapeutic granulocyte transfusions in 1993. Blood 1993; 81: 1675-1678.
25. Spiekermann K, Emmendoerffer A, Elsner J et al. Changes in light-scatter profile, membrane depolarization and calcium mobilization of neutrophils induced by G-CSF in vivo. Br J Haematol 1994; 88: 506-514.
26. Kerst LM, De Haas M, Van der School CE et al. Recombinant granulocyte colony-stimulating factor administration to healthy volunteers: induction of immunophenotypically and functionally altered neutrophils via an effect on myeloid progenitor cells. Blood 1993; 82: 3265-3272.
27. Wiltschke C, Krainer M, Wagner A et al. Influence of in vivo administration of GM-CSF and G-CSF on monocyte cytotoxicity. Exp Hematol 1995; 23: 402-406.
28. De Haas M, Kernst JM, Van der School CE et al. Granulocyte colony-stimulating factor administration to healthy volunteers: analysis of immediate activating effects on circulating neutrophils. Blood 1994; 84: 3885-3894.
29. + cells in granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood mononuclear cells induce secretion of interleukin-6 and G-CSF by marrow stroma. Blood 1996; 87: 574-580.
30. Pan L, Delmonte J, Jalonen CK, Ferrara JLM. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood 1995; 86: 4422-4429.
31. Hartung T, Docke WD, Gantner F et al. Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood 1995; 85: 2482-2489.
32. Cassatella MA. The production of cytokines by polymorphonuclear neutrophils. Immunol Today 1995; 16: 21-26.
33. Pollmacher T, Korth C, Mullington J et al. Effects of granulocyte colony-stimulating factor on plasma cytokine and cytokine receptor levels and on the in vivo host response to endotoxin in healthy men. Blood 1996; 87: 900-905.
34. Richie ER, Hiliard JK, Gilmore R, Gillepsie DJ. Human milk-derived lactoferrin inhibits mitogen and alloantigen-induced human lymphocyte proliferation. J Reprod lmmunol 1987; 12: 137-148.
35. Levay PF, Margarctha V. Lactoferrin: a general review. Haematolagica 1995; 80: 252-267.
36. Crouch SPM, Slater KJ, Fletcher J. Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin. Blood 1992; 80: 235-240.
37. Heaney ML, Golde DW. Soluble cytokine receptors. Blood 1996; 87: 847-857.
38. Re F, Mengozzi M, Muzio M et al. Expression of interleukin1 receptor antagonist (IL-1ra) by human circulating polymorphonuclear cells. Eur J lmmunol 1993; 23: 570-573.
39. Guillaume T, Sekhavat M, Rubinstein DB et al. Defective cytokine production following autologous stem cell transplantation for solid tumors and hematologic malignancies regardless of bone marrow or peripheral origin and lack of evidence for a role for interleukin-10 in delayed immune reconstitution. Cancer Res 1994; 54: 3800-3807.
40. Mazzone A, Ricevuti G. Leukocyte CD11/CD18 integrins: biological and clinical relevance. Haematologica 1995; 80: 161-175.
41. Esnault S, Benbernou N, Lavaud F, Guenounou M. Spontaneous CD30 mRNA expression in peripheral blood mononuclear cells from atopic patients with high IgE plasma levels. Clin Exp Immunol 1996; 106: 67-72.
42. Bengtsson A, Johansson C, Tengvall Linder M et al. Not only Th2 cells but also Th1 and Th0 cells express CD30 after activation. J Leuk Biol 1995; 58: 683-689.